Advocacy group seeks ban on pelvic surgical mesh

(AP) -- A consumer advocacy group is calling on government regulators to ban a type of surgical mesh used to treat pelvic collapse, saying it exposes patients to serious risks.

Public Citizen sent a petition to the asking the agency to ban pelvic surgical mesh inserted through the vagina. About 75,000 women had prolapse surgery with forms of the mesh last year, according to the FDA.

FDA announced last month that complications with mesh are higher than previously estimated, with many women experiencing pain, bleeding and infection. Public Citizen said mesh offers no benefit over traditional surgery with stitches.

"Even the FDA seriously questions the safety and effectiveness of these mesh products, so they should be removed from the market immediately," said Public Citizen's Dr. Michael Carome.

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

FDA: pelvic mesh for women riskier than thought

Jul 13, 2011

A product commonly used in surgery to treat incontinence and other women's health problems causes far more complications than previously thought and is likely exposing patients to unnecessary risks, according to U.S. health ...

Researchers offer hope to prolapse sufferers

May 17, 2011

Scientists in Scandinavia have found a new way to treat sufferers of pelvic organ prolapse. Presented in the New England Journal of Medicine, their study reveals that the use of synthetic mesh can have a more ...

Synthetic mesh can improve outcome of prolapse surgery

May 12, 2011

(Medical Xpress) -- A Nordic multicentre study, headed by researchers from Karolinska Institutet, shows that pelvic organ prolapse surgery using synthetic mesh can be more effective than traditional surgery. The advantages ...

Watchdog group makes 2nd push to ban diet pill

Apr 18, 2011

(AP) -- For the second time in five years, public health advocates are calling on the Food and Drug Administration to ban a fat-blocking drug sold over-the counter and via prescription, pointing to new reports of kidney ...

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

Jul 24, 2014

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

User comments